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Loureirin B (LrB) is a constituent extracted from traditional Chinese medicine Resina Draconis.
It has broad biological functions and an impressive immunosuppressive effect that has been
supported by numerous studies. However, themolecular mechanisms underlying Loureirin B-
induced immune suppression are not fully understood.We previously reported that Loureirin B
inhibited KV1.3 channel, calcium ion (Ca
2+) influx, and interleukin-2 (IL-2) secretion in Jurkat
T cells. In this study, we applied CRISPR/Cas9 to edit KV1.3 coding gene KCNA3 and
successfully generated a KV1.3 knockout (KO) cell model to determine whether KV1.3 KOwas
sufficient to block the Loureirin B-induced immunosuppressive effect. Surprisingly, we
showed that Loureirin B could still inhibit Ca2+ influx and IL-2 secretion in the Jurkat
T cells in the absence of KV1.3 although KO KV1.3 reduced about 50% of Ca
2+ influx
and 90% IL-2 secretion comparedwith that in the wild type cells. Further experiments showed
that Loureirin B directly inhibited STIM1/Orai1 channel in a dose-dependent manner. Our
results suggest that Loureirin B inhibits Ca2+ influx and IL-2 secretion in Jurkat T cells by
inhibiting both KV1.3 and STIM1/Orai1 channels. These studies also revealed an additional
molecular target for Loureirin B-induced immunosuppressive effect, which makes it a
promising leading compound for treating autoimmune diseases.
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INTRODUCTION
Loureirin B (LrB) is a Resina Draconis (RD)-derived flavonoid and a traditional Chinese medicine
bearing multifaceted effects on numerous diseases (Fan et al., 2014; Bai et al., 2015). LrB was reported
to be a plasminogen activator inhibitor-1 (PAI-1) that promoted blood circulation and reduced the
size of arterial thrombus (Jiang et al., 2017). LrB alone or combined with other RD constituents
inhibited voltage-gated sodium (NaV) channel, transient receptor potential vanilloid 1 channel, and
acid-sensing ion channel in dorsal root ganglion (DRG) neurons and ameliorated inflammatory pain
(Chen et al., 2018; Wan et al., 2019). Besides its analgesic effect, LrB and RD also possess promising
immunosuppressive effects. The ethylacetated RD inhibited inflammatory responses in vascular
smooth muscle cells and macrophages by suppressing ROS production (Heo et al., 2010). A recent
study showed that LrB could reduce the severity of inflammation in Crohn’s disease via inhibiting
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factor-alpha (TNF-α) (Sun et al., 2020). However, the
mechanisms behind LrB-induced immune suppression have
not been fully elucidated.
Ion channels are critically involved in regulating proliferation
and apoptosis of lymphocytes (Cahalan and Chandy, 2009).
Calcium signaling plays a pivotal role in linking ion channels
and numerous functions of T lymphocytes (Feske et al., 2015).
When an antigen stimulates a T cell and binds to a T cell receptor
(TCR), the downstream phospholipase C gamma (PLCc) will
hydrolyze PIP2 into DAG and inositol triphosphate (IP3) (Zhong
et al., 2016; Zhu et al., 2017). The newly synthesized IP3 binds to
IP3 receptor (IP3R) on endoplasmic reticulum (ER) membrane
and depletes calcium ion (Ca2+) stored in ER pool (Zhong et al.,
2016; Cao et al., 2019). Another ER membrane protein - stromal
interaction molecule (STIM) - could sense Ca2+ depletion in ER
and change its own conformation to contact and subsequently
open a Ca2+ channel - Orai channel on the plasma membrane
(Lewis, 2020). This process is named Store-operated Calcium
Entry (SOCE) and results in Ca2+ influx which ultimately
activates the downstream signaling pathways such as CaM-
CaN-NFATc1 and NFκB to produce inflammatory cytokines
(Feske et al., 2012; Trebak and Kinet, 2019). During these
processes, the STIM1/Orai1 complex - also called calcium
release-activated calcium (CRAC) channel - is the “major
player” to trigger immune responses of T cells, while other ion
channels, such as potassium ion (K+) channel, could modulate
calcium signals by changing the membrane potential of T cells
and providing a driving force for Ca2+ entry (Cahalan and
Chandy, 2009).
KV1.3 is a predominantly expressed K
+ channel in T cells
(Nicolaou et al., 2009) and regulates immune responses
stimulated by antigens and cell volume of T cells (Nicolaou
et al., 2009; Bobak et al., 2011). Pharmacological blockade of
KV1.3 in myelin basic protein - specific encephalitogenic T cell
line inhibited cytokine secretion through reducing Ca2+ influx,
which improved encephalomyelitis (EAE) symptoms in rats
(Beeton et al., 2001). KV1.3 blockade also suppressed the
activation and motility of TEM (memory effector T) cells and
delayed-type hypersensitivity in rats (Matheu et al., 2008).
Surprisingly, although KV1.3 plays an important role in
T cells, KV1.3 knockout (KO) mice lived normally and their
immune systems showed no impairment (Koni et al., 2003). The
expression level of chloride ion (Cl−) channels was found to
have increased 10-fold in T lymphocytes from these KO
animals, which could compensate for the function of KV1.3
to sustain a normal membrane potential and did not affect
proliferation or activation of T cells (Koni et al., 2003). Another
report studied the effects of KV1.3 deletion in the EAE model
and found that the number of activated CD4+ T cells and
secretion of IFN-γ and IL-17 in KV1.3 KO mice were all
decreased significantly (Gocke et al., 2012). A recent study
showed that T helper (Th) cells isolated from the KV1.3 KO
mice developed into a novel type of Th cell which differed in
gene expression and functions compared with Th cell in wild
type animals when stimulated with Myelin oligodendrocyte
glycoprotein (MOG) (Grishkan et al., 2015). These
inconsistent results in KV1.3 KO mice suggest that selective
KV1.3 deletion in specific lymphocyte type might help to
pinpoint the mechanisms underlying KV1.3-mediated
regulation of immune responses in healthy or pathological
organisms.
We previously used Jurkat T cell as a model to study the effects
of LrB and reported that LrB inhibited KV1.3 currents, Ca
2+
influx, and IL-2 release in a dose-dependent manner (Yin
et al., 2014). In this study, we applied CRISPR/Cas9 system
to knock out KCNA3 gene to explore whether KV1.3 deletion
could block effects of LrB on Ca2+ influx and cytokine
secretion. We showed that KO KV1.3 in Jurkat T cell
decreased but did not abolish the effects of LrB on Ca2+
influx and IL-2 secretion. We further demonstrated that
LrB could decrease Ca2+ influx and IL-2 secretion
through inhibiting STIM1/Orai1 channels in the absence
of KV1.3. These findings suggest that LrB has an




LrB was synthesized by our group (Supplementary Scheme S1)
and dissolved in DMSO. KV1.3 inhibitor ADWX-1 was
purchased from More Biotechnology Co. Ltd. (Cat. MPK-
001A, Wuhan, China) and dissolved in double-distilled
water. Agonist of T cell - Concanavalin A (ConA) was
purchased from MP Biomedicals (Cat. 195,283, Santa Ana,
CA, United States) and dissolved in 1x Phosphate Buffer
Saline (PBS). Calcium-ATPase inhibitor Cyclopiazonic Acid
(CPA) was purchased from Sigma-Aldrich (Cat. C1530,
St.Louis, MO, United States) and dissolved in DMSO. SKCa
inhibitor Scytx was purchased from More Biotechnology Co.
Ltd. (Cat. MPK-001C, Wuhan, China).
Cell Culture
Jurkat T cell line was bought from National Platform of Cell Line
Resource for Sci-Tech (Wuhan, China). Wild type and KV1.3
knockout Jurkat T cells were suspended in culture medium
which consisted of Roswell Park Memorial Institute (RPMI)
1,640 basic (Cat. C11875500, Gibco, NY, United States)
supplemented with 10% fetal bovine serum (FBS) (Cat.
40130ES76, YESEN, Shanghai, China) and 1% Penicillin-
Streptomycin (Cat. 15070063, Gibco, NY, United States).
Cell density was counted using Cellometer K2 (Nexcelom,
San Diego, CA, United States) and suspended cells were
seeded in 6-well plate with 1 × 106 cells/well in 2 ml
culture medium under 5% CO2 and 37°C. After being
pretreated with 0.01, 0.1, or 1 μM LrB for 1 h, 10 μg/ml
ConA was added in the culture medium as stimulus group,
and the same volume of 1x PBS was added in control group.
After incubating with ConA or PBS for 24 h, the culture
medium was harvested in Eppendorf (Ep) tube for ELISA
assay (Cat. DY202-05, R&D, Minneapolis, MN,
United States) to test IL-2 secretion by Jurkat T cells with
or without ConA stimulation.
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sgRNA Design and Plasmid Construct
sgRNA was designed to target the first exon (exon1) of KCNA3
gene, which consists of the functional domain of KV1.3 subunit.
The target DNA sequence was submitted to http://crispr.mit.edu/
website and two sgRNA sequences with the highest editing
efficiency scores were selected and synthesized by Tskingke
Company (Peking, China). Sequences of DNA fragments
expressing sgRNAs CTACCCCGCCTCGACGTCGC (sgRNA1)
and GAGATCCGCTTCTACCAGCT (sgRNA2) are used in our
study (Supplementary Figures S1A,B). The pX458 plasmid is a
gift from Lu Xue lab (School of Life Sciences, Central-South
University for Nationalities, Wuhan, China) and used to express
SpCas9 and sgRNA simultaneously to edit the target genes. This
plasmid expresses GFP as a fluorescence reporter to indicate
vector transfection of the cells. The plasmid was digested with
Fast Digest BbsⅠ enzyme (Cat. ER1011, Thermo Scientific,
Waltham, MA, United States) and linked with synthesized
sgRNA fragments by T4 ligase (Cat. D2011A, Kyoto, Takara,
Japan). The sgRNA sequence insertion in plasmid was confirmed
by gene sequencing (Supplementary Figure S1A,B).
Electroporation and Cell Sorting
Cultured Jurkat T cells were transfected with the constructed
plasmids using a CTX-1500A EX Electroporator (Celetrix
Biotechnologies, Manassas, VA, United States). Cultured
Jurkat T cells were suspended into single cells and sorted with
Fluorescence Activated Cell Sorter (FACS) (MA900, Sony,
Tokyo, Japan) 48 h after transfection. The single cells
expressing GFP were selected and seeded in a 96-well plate
and passed to a 24-well and then a 6-well plate to amplify the
single colony. Genomes and proteins were extracted from each
colony for confirmation of KV1.3 KO.
Confirmation of Gene Editing Efficiency
Before cell sorting by FACS, Jurkat T cells transfected with the
constructed plasmids were tested for editing efficiency first.
Genomes in different groups were extracted using Genome
Extraction kit (Cat. 7E491E0, Vazyme, Suzhou, China) and the
target sequence was amplified with Polymerase Chain Reaction
(PCR) from the genome. The PCR primers were FP: GTCATC
AACATCTCCGGGCT, RP: TACTCGAAGAGCAGCCACAC.
Products of PCR were used for T7EN1 digestion and DNA gel
first. Gray analysis of the digested fragments compared with the
whole quantities of the PCR products was used to calculate the
editing efficiency of CRISPR/Cas9. After we obtained the single
cell colony, the target sequence was amplified with PCR and
ligated into commercial pMD™19 T vector (Cat. 6,013, Kyoto,
Takara, Japan) to check the mutation of each single colony edited
by PX458-sgRNA1 or PX458-sgRNA2.
Western Blot
Cultured cells were collected by centrifugation at 6,000 rpm for
5 min and washed with ice cold 1x PBS twice. Cells were lysed
with Radio Immunoprecipitation Assay (RIPA) solution (Cat.
P0013B, Beyotime, Peking, China) for 30 min. The lysis solution
was centrifuged again at 12,000 rpm under 4°C for 15 min and the
supernatant was collected and mixed with 2x Sodium dodecyl
sulfate (SDS) loading buffer and boiled for 5 min. Before loading,
the total protein concentration of each group was determined by
BCA kit and scanned with a microplate photospectrometer
(SPARK 10M, Tecan, Hombrechtikon, Swiss). Proteins were
loaded based on the total protein concentration of each group
to assure equal quantities per lane. Proteins were separated on a
10% SDS-polyacrylamide gel and transferred to Polyvinylidene
fluoride (PVDF) membranes (Millipore, Billerica, MA). The
membranes were blocked with 10% nonfat milk and incubated
at 4°C overnight with the following antibodies: rabbit polyclonal
antibody against KV1.3 (1:1,000, Cat. APC101; alomone labs,
Jerusalem, Israel) and rabbit polyclonal antibody against β-actin
(1:1,000, Cat. AC006; Abclonal, Boston, United States). After
washing in Tris-Buffered Saline (TBS) with 0.3% Tween three
times for 45 min, the membranes were incubated with HRP-
conjugated goat anti-rabbit IgG (1:10,000, Cat. AS014; Abclonal,
Boston, United States) for 2 h at room temperature.
Chemiluminescent signals were generated using a Super Signal
West Pico trial kit (Pierce Protein Biology, Thermo Fisher
Scientific, Waltham, MA, United States) and detected using
the ChemiDoc XRS System (Bio-Rad, Hercules, CA,
United States). Image Lab software (Bio-Rad, Hercules, CA,
United States) was used for background subtraction and
quantification of immunoblotting data.
Electrophysiology Recording
Whole-cell patch-clamp recordings were performed using an
EPC9 amplifier (HEKA Elektronik, Lambre-cht/Pfalz,
Germany) at room temperature (22–24°C). Pipettes pulled
from borosilicate glass (Cat. BF 150-86-10, Sutter Instrument
Co., Novato, CA, United States) had resistances of 2–4 MΩ when
filled with the internal solution. The internal pipette solution for
recording voltage-gated potassium (KV) currents contained KCl
140 mM, MgCl2 1 mM, EGTA 1 mM, Na2ATP 3 mM, and
HEPES 10 mM (pH 7.3 with KOH). For recording CRAC,
currents contained Cs Methanesulfonate 120 mM, MgCl2
10 mM, EGTA 4 mM, CaCl2 2 mM, and HEPES 10 mM (pH
7.3 with CsOH). The formula of internal pipette solution for
recording small conductance Ca2+-activated K+ channels (SKCa)
currents was calculated by Winmaxc software to guarantee that
the concentration of free Ca2+ in cytoplasm was kept at 2 μM and
contained KCl 140 mM, HEPES 10 mM, HEDTA 5 mM, and
CaCl2 2 mM (pH 7.2 with KOH). The external solution for
recording KV currents contained KCl 5 mM, NaCl 140 mM,
HEPES 10 mM, CaCl2 2 mM, MgCl2 1 mM, and D-Glucose
10 mM (pH 7.4 with NaOH). For recording CRAC currents,
the external solution contained NaCl or NaGlu 140 mM, KCl
5 mM, HEPES 10 mM, or CaCl2 2.5 mM (pH 7.3 with NaOH).
For recording SKCa currents the external solution contained KCl
140 mM, MgCl2 1 mM, Glucose 10 mM, CaCl2 2 mM, and
HEPES 10 mM (pH 7.4 with KOH). KV currents were elicited
by +50 mV, 400 ms depolarizing pulse from the holding potential
of −60 mV every 20 s. CRAC currents were elicited by +10 mV,
100 ms depolarizing ramp from the holding potential of -60 mV
every 10 s, and SKCa currents were elicited by from −100 mV to
+100 mV for 200 ms depolarizing ramp from the holding
potential of 0 mV every 10 s. Using IGOR (WaveMetrics, Lake
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Oswego, OR, United States) software, concentration–response
relationships were fitted according to modified Hill equation:
Itoxin/Icontrol  1/1 + ([drug]/IC50), where I is the steady-state
current and [drug] is the concentration of LrB. The parameter to
be fitted was concentration of half-maximal effect (IC50).
IL-2 Secretion
IL-2 secretion from Jurkat T cells was measured using an ELISA
kit (Cat. DY202-05, R&D System, Minneapolis, MN,
United States) following manufacturer’s instructions. The
goodness of fit for the ELISA kit was between 10 pg/ml to
1,000 pg/ml. Cells were centrifuged at 1,500 rpm for 10 min,
and the supernatants were collected to measure IL-2
concentrations. Reactions were performed in 96-well plates
coated with the capture antibody and stopped with 1 M
phosphoric acid. Absorbance was measured at 450 nm. Each
experiment was repeated at least three times in duplicate.
Calcium Imaging
Jurkat T cells were loaded with 4 μMFura-2 AM (Cat.40702ES50,
YEASEN, Shanghai, China) for 60 min at 37 °C. Cells were then
washed three times and incubated in Hank’s Balanced Salt
Solution (HBSS) for 30 min at room temperature before use.
Fluorescence at 340 and 380 nm excitation wavelengths was
recorded on an inverted Nikon Ts2R microscope (Tokyo,
Japan) equipped with 340, 360, and 380 nm excitation filter
wheels using NIS-Elements imaging software (Nikon). 510 nm
Fura-2 emission fluorescence ratios (F340/F380) reflect changes
in intracellular Ca2+ concentration ([Ca2+]i) upon stimulation.
Data were obtained from 100 to 250 cells in time-lapse images
from each coverslip. To make sure that Fura-2 loading was the
same in individual cells, we selected the cells with the same
baseline level of fluorescence intensity at the beginning of the
calcium imaging experiment.
Statistics Analysis
All data are presented as mean ± SEM for independent
observations. Statistical analysis of differences between groups
was carried out using one-way ANOVA combined with Turkey’s
post-hoc test. p < 0.05 was considered significantly different.
RESULTS
CRISPR/Cas9-Mediated KV1.3 Knockout in
Jurkat T Cells
We constructed the pX458-sgRNA1 and pX458-sgRNA2
plasmids to express Cas9 and sgRNA simultaneously and
confirmed the insertion of sgRNA with sequencing
(Supplementary Figure S1A,B). The Jurkat T cells were
transfected by electroporation with the constructed plasmids
that also express GFP as a reporter (Supplementary Figure
S1C). The target sequence was amplified with PCR and
digested by T7EN1 enzyme to confirm editing efficacy. If the
target sequence had been edited by CRISPR/Cas9, the hybridized
double strand DNA would be mismatched and form a neck and
ring structure. T7EN1 enzyme could recognize the mismatched
DNA structure and cut it into small fragments. DNA gel of the
digestion products showed that the control group only had one
single band, which is consistent with the molecular weight of the
target sequence, while sgRNA1 and the sgRNA2 editing groups
both had bands smaller than the target sequence. These bands
matched the fragments cut by T7EN1 (Supplementary Figure
S1D). The editing efficiencies of sgRNA1 and sgRNA2 calculated
according to the gray analysis of T7EN1 digestion were 25 and
34%, respectively.
To obtain the KCNA3 knock out Jurkat T cell, we used FACS
to select GFP-expressing cells which had been transfected with
pX458-sgRNA plasmid and edited by CRISPR/Cas9 system.
Single cells were then seeded in a 96-well plate and cultured
for colony expansion. Proliferated cells were harvested and lysed
with RIPA solution to extract proteins to examine the expression
of KV1.3 using Western Blot. We found that cell colonies edited
either by sgRNA1 or sgRNA2 expressed much less KV1.3 than the
control group (Figure 1A). KV1.3 expression in the colony edited
by sgRNA2 was lower than that by sgRNA1, and almost
completely knocked out by CRISPR/Cas9 editing (Figure 1A).
We therefore used the sgRNA2-edited cells for further
experiments.
The genome of sgRNA2-edited cells was extracted and the
target sequence of KV1.3 was amplified with PCR. The PCR
product was sequenced and nucleotide deletion started around
the recognition site of sgRNA, which indicates Indel mutations
from this site. To further confirm the mutation of the targeted
sequence, the PCR fragments were ligated into pMD™19 T vector
and sequenced again. We found that one cell colony (KO-1) lost
one bp (Figures 1C,F) compared with the wild type group
(Figures 1B,F). Another cell colony (KO-2) lost four and five
bp (Figures 1D–F), respectively. We compared the sequences of
KO-1 and KO-2 with wild type sequence and confirmed that
these two colonies both had frameshift mutations starting from
the sgRNA guided site and changed the open reading frame of
KCNA3, thus changing the normal KV1.3 translation.
KV1.3 Current Elimination in Jurkat T Cell
After CRISPR/Cas9 Editing
After confirmation of KCNA3 editing efficiency and KV1.3
expression deletion, we studied the electrophysiology
properties of the KV1.3 KO cells and compared the changes in
membrane currents with wild type cells. Previous studies
showed that KV1.3 and type II SKCa (KCa2.2) channels were
the twomain types of K+ channels expressed in Jurkat T (Cahalan
and Chandy, 2009; Valle-Reyes et al., 2018). To determine
whether KO KV1.3 eliminates the function of KV1.3 in Jurkat
T cell, we used whole-cell patch-clamp recording to measure K+
currents in Jurkat T cells. The holding potential was set as −60mV
and depolarized to +50 mV for 400 ms and a Ca2+-free external
solution with added tetrodotoxin (TTX) to block NaV currents
was used to record K+ currents. A large outward current was
recorded in wild type Jurkat T cells, which was blocked by the
KV1.3 inhibitor ADWX-1 (Figure 1G). The outward current
amplitude was much smaller in the KV1.3 KO Jurkat T cells and
was resistant to 10 nM ADWX-1 (Figure 1H), suggesting that
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Jurkat T cells edited by CRISPR/Cas9 system completely lost
KV1.3 conducted current.
LrB-Induced Inhibiton of IL-2 Secretion in
Jurkat T Cells
Concanavalin A (ConA) is a phytohemagglutinin activating
T cells and increasing KV1.3 expression on T cell membrane
(Yin et al., 2014; Yabuuchi et al., 2017). ConA also induced IL-2
release through a Ca2+-dependent pathway in Jurkat T cells
(Sharma et al., 2019). We therefore used ConA as a cytokine
stimulant. The control group and KV1.3 KO Jurkat T cells
under the same culture conditions were pretreated with 0.01,
0.1, or 1 μM LrB separately for 1 h, then 10 ug/mL ConA was
added in the culture medium to activate Jurkat T cells. 24 h
after ConA incubation, the supernatant of culture medium
was collected and tested for IL-2 concentration using an
ELISA kit. The quantity of IL-2 secreted by the KV1.3 KO
FIGURE 1 | Confirmation of Kv1.3 KO in Jurkat T cells. (A)Western Blot for KV1.3 expression in wild type and Kv1.3 KO cells (n  3); (B) Sequencing of target gene
in wild type Jurkat T cells; (C) Sequencing of target gene in KO-1 colony which has one bp nucleotide loss compared with wild type, the black arrow indicates the start
point of CRISPR/Cas9 editing; (D,E) KO-2 colony has four and five bp nucleotide loss respectively, the black arrow indicates the start point of CRISPR/Cas9 editing; (F)
Alignment of the wild type, KO-1 and KO-2 Jurkat T cell colonies; (G) Membrane current of a wild type Jurkat T cell was irreversibly inhibited by 10 nM ADWX-1
(n  3); (H) Membrane current of a Kv1.3 knockout Jurkat T cell was nearly abolished and the remaining residual current was not further inhibited by ADWX-1 (n  3).
FIGURE 2 | Effects of Kv1.3 KO on IL-2 secretion. (A) Changes of IL-2 secretion in wild type Jurkat T cells under control, ConA stimulation, and LrB treatment with
different concentrations (n  5); (B) Changes of IL-2 secretion in the Kv1.3 KO Jurkat T cells under control, ConA stimulation, and LrB treatment with different
concentrations (n  5). Data were presented as mean ± SEM. Statistical analysis of differences between groups was carried out using one-way ANOVA combined with
Turkey’s post-hoc test. ***, p < 0.001.
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group (8.73 ± 0.66 pg/ml) without any treatment was 10-fold
lower compared with the wild type group (85.00 ± 6.46 pg/
ml) (Figures 2A,B). Surprisingly, LrB in a relatively low
concentration still significantly inhibited IL-2 secretion
although most IL-2 release was blocked by KO KV1.3
(Figure 2B). Moreover, the inhibitory effect of LrB on IL-
2 secretion in the wild type Jurkat T cells was dose-dependent
(p < 0.001) in both wild type and KV1.3 KO cells treated with
0.01, 0.1, or 1 μM LrB. Therefore, LrB could inhibit IL-2
release in the absence of KV1.3.
Decreased Ca2+ Influx in KV1.3 KO Jurkat
T Cells
KV1.3 conducts an outward K current and hyperpolarizes the
membrane potential, which provides a driving force for Ca2+
influx (Chandy et al., 2004; Nicolaou et al., 2009) to maintain
T cell Ca2+ homeostasis (Nicolaou et al., 2009; Trebak and Kinet,
2019). Our results showed that LrB reduced IL-2 secretion in the
absence of KV1.3 KO in Jurkat T cells, which suggests that LrB
might be able to directly regulate intracellular Ca2+ concentration
([Ca2+]i) in Jurkat T cells. To test this possibility, we examined
FIGURE 3 | Effects of LrB on [Ca2+]i in Jurkat T cells. (A) [Ca
2+]i responses of wild type Jurkat T cells before (left) and after (right) 2 mM Ca
2+perfusion; (B) [Ca2+]i
responses of wild type Jurkat T cells pretreated with 10 μM LrB before (left) and after (right) 2 mM Ca2+perfusion; (C) [Ca2+]i responses of the Kv1.3 KO Jurkat T cells
before (left) and after (right) 2 mM Ca2+perfusion; (D) [Ca2+]i responses of the Kv1.3 KO Jurkat T cells pretreated with 10 μM LrB before (left) and after (right) 2 mM
Ca2+perfusion; (E,F) Representative traces of F340/F380 ratio show [Ca2+]i in wild type Jurkat T cells treated with and without LrB; the first small peak was caused
by 10 μMCPA depletion of ER Ca2+store, the second peak was caused by 2 mMCa2+perfusion; (G,H). Representative traces of F340/F380 ratio in the Kv1.3 KO Jurkat
T cells treated with and without LrB; (I) Statistic analysis of changes in F340/F380 in the wild type and Kv1.3 KO cells after 2 mMCa2+perfusion between control and LrB
treatment groups (n  3, 100–250 cells were selected each batch). Data were presented as mean ± SEM. Statistical analysis of differences between groups was carried
out using one-way ANOVA combined with Turkey’s post-hoc test. ***, p < 0.001.
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whether LrB affects [Ca2+]i after Ca
2+ stored in ER was depleted
by the Ca2+-ATPase inhibitor CPA. After CPA exhausts Ca2+ in
ER, CRAC channel will sense the Ca2+ depletion and mediate
Ca2+ influx (Hoth and Penner, 1992; McCarl et al., 2010). We
incubated the cells with 0 Ca2+ HBSS first and conducted calcium
imaging to observe the effects of LrB on [Ca2+]i. 10 μM CPA
caused a small instant [Ca2+]i increase in Jurkat T cells. After CPA
treatment for 6 min, perfusion with HBSS adding 2 mM Ca2+ led
to a large [Ca2+]i peak followed by a stable plateau
(Figure 3E,G). Interestingly, the [Ca2+]i reached a peak
but would not go down when the cells were pretreated
with 10 μM LrB in both wild type and KV1.3 KO groups
(Figure 3F,H), which suggests that LrB might block the Ca2+
reuptake of the Jurkat T cells. F340/F380 ratio representing
[Ca2+]i of wild type Jurkat T cells was changed by 0.21 ± 0.024
after 2 mM Ca2+ perfusion, while in the KV1.3 KO Jurkat
T cells it was changed by 0.14 ± 0.019, which is significantly
smaller than the wild type group (Figure 3I). LrB
pretreatment inhibited Ca2+ influx induced by 2 mM
Ca2+in both the wild type (0.1748 ± 0.015) and KV1.3 KO
Jurkat T cells (0.053 ± 0.022) (Figure 3I). Although [Ca2+]i
changes in the KV1.3 KO Jurkat T cells were significantly
smaller than that in the wild type cells, LrB further reduced
the [Ca2+]i in the KV1.3 KO cells from 0.14 ± 0.019 to 0.053 ±
0.022 (Figure 3I). These results suggest that LrB inhibited
Ca2+ influx in the absence of KV1.3, which is consistent with
the results for IL-2 secretion.
Inhibition of STIM1/Orai1 Current by LrB
KV1.3 and KCa2.2 are two main K
+ channels expressed in Jurkat
T cells and regulate membrane potential and T cell activation
(Grissmer et al., 1992; Desai et al., 2000). To exclude the
possibility that LrB affects SKCa to inhibit IL-2 secretion or
Ca2+ influx in KV1.3 KO cells, we transfected HEK293 T cells
with KCa2.2 plasmids and recorded SKCa currents with or without
LrB treatment. As predicted, 10 nM SKCa inhibitor Scytx (Wu
et al., 2004) nearly blocked the SKCa currents (Figure 4A). In
marked contrast, a relatively high concentration (100 μM) of LrB
could not inhibit SKCa currents (Figure 4B), suggesting that SKCa
is unlikely the mediator of LrB’s inhibition on IL-2 release and
Ca2+ influx.
Although KV1.3 and KCa2.2 provide the driving force for Ca
2+
influx, STIM1/Orai1 channel is the “key player” to trigger Ca2+
influx after ER depletion and T cell activation (McCarl et al., 2010;
Trebak and Kinet, 2019). Since LrB continued to decrease Ca2+
influx after KV1.3 knockout and did not inhibit SKCa, we
speculated that LrB might directly inhibit STIM1/Orai1
channel and block Ca2+ influx in Jurkat T cells, resulting in
immunosuppression. To test this possibility, we transfected the
HEK293 T cells with STIM1 and Orai1 plasmids. 24 h after
transfection, cells were stimulated with a ramp protocol
(depolarizing the cell with a slope from the holding potential
−60 to 10 mV) to record STIM1/Orai1 current. Indeed, LrB
inhibited the STIM1/Orai1 current in a concentration-
dependent manner. Moreover, the inhibition was partly
reversed by washing off LrB in the external solution
(Figure 5A). Statistics analysis with Igor Pro four Hill
software showed that LrB inhibited STIM1/Orai1 current with
an IC50 of 17.11 ± 2.17 μM (Figure 5B).
DISCUSSION
In this study, we used Jurkat T cell as a T cell model and applied
CRISPR/Cas9 system to KO KV1.3 to study the effects of LrB on
Ca2+ influx and cytokine release in the absence of KV1.3. We
found that although KO KV1.3 reduced IL-2 secretion and Ca
2+
influx after T cell activation, it did not abolish the inhibitory effect
of LrB on IL-2 secretion and Ca2+ influx. We further
demonstrated that LrB did not affect SKCa channels but
directly inhibited the STIM1/Orai1 channel in heterologous
cells. Our results suggest that LrB acts on multiple targets in
Jurkat T cells to impact cytokine production and release.
Recognizing the promiscuous property of LrB-induced
inhibition of T cell function should shed new light on its
immunosuppressive functions.
KV1.3 and SKCa channels are two predominant K channels
expressed in T lymphocytes (Valle-Reyes et al., 2018; Trebak and
Kinet, 2019). Both of them can regulate membrane potential and
provide a driving force for Ca2+ influx in T cells (Cahalan and
Chandy, 2009; Nicolaou et al., 2009), which subsequently
modulates proliferation, activation, and apoptosis of T cells
(Cahalan and Chandy, 2009; Valle-Reyes et al., 2018). It was
reported that KV1.3 joins the immunological synapse (IS) of
T cells which contacts with the antigen-presenting cell (APC)
FIGURE 4 | Effects of LrB on SKCa currents. (A) Representative whole-
cell currents recorded in KCa2.2 expressing HEK293T cells with or without the
treatment of 10 nM Scytx. Black trace represents the baseline control current,
red trace represents the currents recorded after Scytx treatment, and
the blue trace is the current under external solution washing off Scytx. (n  5).
(B) Representative whole-cell currents recorded in KCa2.2 expressing
HEK293 T cells with and without the treatment of 100 μM LrB. Black trace
represents the baseline control current, red trace represents the currents
recorded after LrB treatment, and the blue one is the current under external
solution washing off LrB (n  5).
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when the antigens activate TCR (Nicolaou et al., 2007; Nicolaou
et al., 2009). The redistribution to IS and function of KV1.3 were
disrupted in many immunology diseases such as systemic lupus
erythematosus and rheumatic arthritis (Nicolaou et al., 2007). To
investigate the mechanisms underlying KV1.3-mediated regulation
of immune responses in diseases, numerous studies have used the
KV1.3 KO animals, which have greatly extended our knowledge
about KV1.3 and its functions in immune system. Initially, KV1.3 KO
mice were found to manifest a normal phenotype with unaltered
T cell proliferation and activation (Koni et al., 2003). On the other
hand, the expression of Cl− channels in T cells in the absence of
KV1.3 was increased 10-fold, which is considered as a compensatory
factor for the loss of KV1.3 to sustain the membrane potential of
T cell and driving force for Ca2+ influx (Koni et al., 2003).
Proliferation of CD4+ T cells and secretion of IL-17 and TNF-α
were significantly decreased when EAE was induced in the KV1.3
KO animals compared with the wild type group (Gocke et al., 2012).
These changes render the Kv1.3 KO mice resistant to EAE and
support KV1.3 as a target to treat autoimmune diseases (Gocke et al.,
2012). Another study using Th cells isolated from the KV1.3 KO
mice expressing MOG-specific TCR (2D2-Kv1.3 KO) demonstrated
that Ca2+ oscillation andNFATc1 activation in Th cells did not differ
between KV1.3 KO and wild type cells after antigen stimulation, but
part of the Th cells grew into a novel phenotype which is similar to
regulatory T (Treg) cells (Grishkan et al., 2015). Collectively, these
studies demonstrated that different types of T cells or the same cells
in different stages may show divergent effects after KV1.3 deletion.
We chose the commonly used Jurkat T cell line and applied CRISPR/
Cas9 to KO KV1.3, which might help to reveal the effects of LrB on
T cells in the absence of KV1.3 acutely since it may avoid the changes
in Cl− channel expression or other molecular compensation
mechanisms during T cell development in vivo. This approach
could be developed into a useful in vitro model to complement
the studies using in vivo KV1.3 KO animals.
STIM1/Orai1 signaling plays pivotal roles in regulating
activation, proliferation, and motility of T cells (Lewis, 2020),
as reflected by the lethality of Orai1 knockout mice (Vig et al.,
2008; Oh-Hora et al., 2013). Humans with Orai1 mutations also
suffer from severe combined immunodeficiency (SCID) (Le Deist
et al., 1995; Feske et al., 2006). STIM1/Orai1 and KV1.3 channels
crosstalk with each other and dynamically regulate Ca2+
homeostasis and the downstream signaling pathways of T cells
(Lioudyno et al., 2008; Nicolaou et al., 2009). It is reported that after
T cell activation, STIM1/Orai1 expression is up-regulated and Ca2+
influx increases through a positive feedback loop (Lioudyno et al.,
2008). In addition to the role of sustaining a hyperpolarization state
of plasma membrane and providing a driving force for Ca2+ influx,
KV1.3 anchors molecules on plasma membranes to stabilize IS and
generate a sustained Ca2+ influx (Hanada et al., 1997; Levite et al.,
2000). Our results from calcium imaging and IL-2 secretion assays
showed that both Ca2+ influx and IL-2 secretion were reduced
significantly in KV1.3 KO cells and the effect on IL-2 secretion was
higher than that for Ca2+ influx. In KV1.3 KO cells, CRAC channels
may still sense Ca2+ depletion in ER and mediate an instant Ca2+
influx when 2mM Ca2+ was present in the external solution,
however, this low level of Ca2+ increase may not be enough to
form a positive feedback loop to further upregulate the downstream
signaling as occurrs in the wild type cells. This may explain the
discrepancy between the changes of Ca2+ influx and IL-2 secretion. A
detailed analysis of the long-term changes of Ca2+ oscillations and
activation of signalingmolecules such as CaN andNFATc1 in KV1.3
KO Jurkat T cell is needed to test this possibility.
We showed that LrB significantly inhibited Ca2+ influx in the
KV1.3 KO Jurkat T cell and STIM1/Orai1 currents in HEK293
T cell. Although IL-2 secretion was largely blocked by KO KV1.3,
the remaining IL-2 was further inhibited by LrB in even at
0.01 uM concentration. This result suggests that LrB is a
potent inhibitor for STIM1/Orai1 in T cells and inhibits IL-2
release in a relatively low concentration. This might be caused by
the fact that other than crosslinking with KV1.3, STIM1/Orai1
were also closely working with other molecules to cooperatively
regulate the activation of T cells (Trebak and Kinet, 2019). For
instance, after the initial Ca2+ influx mediated by CRAC channel,
mitochondria and plasma membrane calcium ATPase (PMCAs)
would move close to STIM1/Orai1 channel in the IS and form a
microdomain where Ca2+ concentration was kept in a lower level
to avoid the Ca2+ inactivation of CRAC channel and keep a
sustained Ca2+ elevation globally to activate Ca2+ signals and
cytokine expression (Quintana et al., 2011). In addition, Orai1,
STIM1/2, and ryanodine receptor type1 (RyR1) could also form
FIGURE 5 | Effects of LrB on STIM1/Orai1 currents. (A) Representative whole-cell currents recorded in STIM1/Orai1 expressing HEK293 T cells after treatment
with 3, 10, or 30 μM LrB, black trace represents the baseline control current. Red, green, and yellow traces represent the currents recorded after the treatment of 3, 10,
and 30 μMLrB, respectively, and the blue trace is the current under external solution washing off LrB. (B)Concentration-response curve of LrB inhibition on STIM1/Orai1
currents (IC50  17.11 ± 2.17 μM, n  5, Mean ± SEM).
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Ca2+ microdomains when T cell was activated and spread Ca2+
increase deeper in the cell (Diercks et al., 2018). The cooperation
between STIM1/Orai1 and PMCAs or RyRs may be able to explain
the inhibition of Ca2+ reuptake by LrB in both wild type and KV1.3
KO Jurkat T cells. Blockade of STIM1/Orai1 by LrB might further
inhibit the function of other Ca2+-related components such PMCAs
and RyRs and block Ca2+ reuptake in the cytoplasm. Ca2+ influx
through CRAC channel is also required for dynamic polymerization
and depolymerization of actin and affects function and motility of
the T cells (Hartzell et al., 2016; Dong et al., 2017). Therefore, CRAC
channel is a highly sensitive Ca2+ modulator through which even a
small decrease of Ca2+ influx could be sensed and amplified by Ca2+
compartmentation and cooperation with other Ca2+ signal
regulation components. Because the numbers of CRAC channel
inhibitor is limited, our finding that LrB is a potent CRAC inhibitor
might provide a new direction for the development of CRAC
inhibitors based on the structure of LrB, which will also facilitate
the use of LrB and its derivatives as potentially highly effective
medicines to treat autoimmune diseases.
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